Prescriber's Letter

61 - 70 of 70 Results

Sort Results:

Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008

Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008

Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008

Patient Education: Patient Handout to Go Along with Your MedGuide for ADHD Drugs June 2008

Chart: Drug Treatment for Attention Deficit Hyperactivity Disorder February 2006

Other: Safety Concerns of ADHD Drugs August 2005

Other: Attention-deficit Hyperactivity Disorder in Adults: An Update October 2004

Other: New Product: Concerta (Extended-Release Methylphenidate) September 2000

Other: Natural Medicines for Attention Deficit-Hyperactivity Disorder (ADHD) September 2000